跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISTA-Ig
首页
药物
VISTA-Ig
VISTA-Ig
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-VISTA ANTIBODIES AND FRAGMENTS
EP 3087098 A2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
CN
EP
US
WO
14 件公开
EP 3722314 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2015
CN
EP
US
6 件公开
VISTA REGULATORY T CELL MEDIATOR PROTEIN, VISTA BINDING AGENTS AND USE THEREOF
US 2024132586 A1
申请人: DARTMOUTH COLLEGE
优先权: 2010
CN
US
WO
11 件公开
Method of identifying anti-VISTA antibodies
US 10899836 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2016
CN
US
4 件公开
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders
US 2014220012 A1
申请人: KING S COLLEGE LONDON
优先权: 2013
CN
US
3 件公开
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
US 10745467 B2
申请人: DARTMOUTH COLLEGE
优先权: 2013
US
3 件公开
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
US 11014987 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2017
US
3 件公开
REDUCING SYSTEMIC REGULATORY T CELL LEVELS OR ACTIVITY FOR TREATMENT OF DISEASE AND INJURY OF THE CNS
EP 4591880 A3
申请人: YEDA RES & DEV
优先权: 2015
EP
WO
2 件公开
ANTI-VISTA ANTIBODIES AND USES THEREOF
US 20240132593 A1
申请人: KINETA INC
优先权: 2021
CN
US
2 件公开
VISTA-BINDING ANTIBODIES AND METHODS OF USE THEREOF
US 20260035466 A1
申请人: ANTHARIS THERAPEUTICS INC
优先权: 2024
US
WO
2 件公开
REDUCING SYSTEMIC REGULATORY T CELL LEVELS OR ACTIVITY FOR TREATMENT OF DISEASE AND INJURY OF CNS
CN 108025068 A
申请人: YEDA RES AND DEVELOPMENT COMPANY LTD
优先权: 2015
CN
第 1 / 2 页
上一页
下一页
药物
反馈